Clinical Trial Detail

NCT ID NCT03687957
Title rhIL-7-hyFc on Increasing Lymphocyte Counts in Patients With Newly Diagnosed Non-lymphopenic Gliomas Following Radiation and Temzolomide
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Washington University School of Medicine
Indications

malignant glioma

Therapies

Radiotherapy + Temozolomide

NT-I7 + Radiotherapy + Temozolomide

Age Groups: adult senior

No variant requirements are available.